Compounded Thyroid Medication: When It Helps, When It Doesn't

Compounded thyroid medications are pharmacy-made T4, T3, or custom T4/T3 ratios that aren't sold commercially. They have a narrow legitimate role: true allergy to inactive ingredients, or a specific ratio your endocrinologist cannot get from approved products. They aren't FDA-approved, potency can vary between batches, and TSH should be monitored more often.

What "compounded" actually means

A compounded medication is one that a licensed pharmacy mixes individually for a single patient, instead of buying it pre-made from a manufacturer. For thyroid hormone, that usually means a pharmacy combining levothyroxine (T4) powder, liothyronine (T3) powder, or both into capsules at a strength or ratio that isn't sold by drug companies [C1][C7]. Common examples include a 4:1 T4/T3 capsule, a slow-release T3 capsule, or a levothyroxine capsule free of a specific dye, lactose, or gluten.

Compounded products are not the same as natural desiccated thyroid (NDT). NDT — brands like Armour or NP Thyroid — is a manufactured, FDA-regulated tablet derived from porcine thyroid glands [C5]. Compounded products are individually prepared by a pharmacy and are not FDA-approved: the FDA does not review the formulation, the potency, or the manufacturing process the way it does for branded or generic tablets [C1]. State pharmacy boards and the United States Pharmacopeia (USP) set standards, but oversight is much lighter than for an industrial product.

The first-line treatment for hypothyroidism in every major guideline remains commercial levothyroxine [C1][C7][C8]. Compounded thyroid sits firmly in the "specific indication, second-line" category.

When a compounded product is actually justified

There are a small number of clinical situations where compounding solves a real problem.

• True allergy or intolerance to inactive ingredients. A patient who has confirmed reactions to dyes, lactose, gluten, or acacia in every commercial levothyroxine tablet may benefit from a custom-compounded capsule that avoids the offending excipient [C1]. Before going there, it's worth trying dye-free generics and the modern liquid or softgel formulations, which already avoid most common allergens [C6]. See our liquid-softgel-levothyroxine article.
• A specific T4/T3 ratio that isn't manufactured. Some patients on combination therapy do best on a fixed ratio (for example, 13:1 or 15:1 T4 to T3) that does not match available tablet strengths. Commercial tablets force a stair-step ratio; a compounded capsule can deliver exactly the prescribed dose [C7]. The 2021 LT4/LT3 consensus document explicitly mentions compounding as one of several options when ratio precision matters [C7].
• Pediatric or very small doses. Newborns and small children sometimes need micro-doses that aren't commercially available, prepared as a liquid or oral suspension.
• Sustained-release T3 in a research or specialist setting. Standard liothyronine has a 24-hour half-life and produces a peak roughly 2–4 hours after dosing. A few endocrinologists prescribe a compounded slow-release T3 to flatten that peak, although evidence for clinical benefit is limited [C7].

These are the legitimate reasons. Outside them, the case for a compounded product is weak.

The risks that don't go away

Even when there is a real indication, compounded thyroid carries trade-offs that don't exist with FDA-approved tablets [C1][C4].

• Potency variability. Levothyroxine has a narrow therapeutic window. A 12% deviation in tablet content is enough to push a patient from euthyroid to subclinical hyper- or hypothyroidism [C1]. FDA-approved tablets are held to a tight content specification; compounded capsules vary more from batch to batch, depending on the pharmacy's equipment, technique, and quality program.
• No FDA approval. Compounded preparations are not reviewed for safety, efficacy, or manufacturing quality the way commercial drugs are [C1]. Bioavailability data, dissolution testing, and shelf-life studies that exist for FDA-approved tablets generally don't exist for a given compounded capsule.
• Batch-to-batch differences. A patient's TSH that was stable on the last refill can drift on the next one if the new batch is even slightly off. This is a real and well-documented source of TSH variability [C1][C4].
• Shorter shelf life. Compounded capsules typically expire in months, not years.
• Higher cost and limited insurance coverage. Most plans don't reimburse compounded prescriptions the way they do for FDA-approved drugs.
• No automatic safety surveillance. Adverse events with branded or generic levothyroxine are tracked through FDA MedWatch. Compounded products fall outside that system.

What does NOT justify a compounded prescription

A compounded recommendation should raise a flag in these situations [C1][C5][C7][C8]:

• "Optimizing free T3" or "treating reverse T3." There is no evidence-based protocol that requires compounded T3 to do this. Most patients with persistent symptoms on adequate levothyroxine benefit more from reconfirming dose, ferritin, vitamin D, and sleep than from a custom ratio.
• "Adrenal-thyroid combos." Compounded products that combine T4/T3 with hydrocortisone, DHEA, or pregnenolone have no supporting trials and add cardiovascular and adrenal-suppression risk.
• Symptom-driven dose changes without TSH. Compounding doesn't fix a missing lab — it just makes it harder to interpret if it later goes wrong.
• "This will reverse your Hashimoto's." No formulation of thyroid hormone — compounded or commercial — reverses the underlying autoimmune process [C2][C3]. Compounded products don't change that.

If a clinician is recommending compounded thyroid for any of these reasons, it's reasonable to ask which trial supports it and what TSH/symptom outcome justifies the switch.

Practical guidelines

1. Start with FDA-approved options. A dye-free generic, a brand-name tablet, or a liquid or softgel formulation will resolve the great majority of dosing and tolerability problems [C6]. See our generic-vs-brand-levothyroxine article.
2. Get the indication in writing. Your endocrinologist will document which specific issue the compounded product is solving — filler allergy, ratio precision, micro-dose — so the prescription has a clear stop criterion.
3. Use a 503A or 503B pharmacy with USP <795> or <797> compliance and good third-party potency-testing records. Ask the pharmacy directly. Reputable compounders will share their quality data.
4. Stay with one pharmacy and one batch source. Switching pharmacies on a compounded prescription resets the dose-response and almost always shifts TSH.
5. Monitor TSH more often. Standard interval after a dose change is 6–8 weeks; on a compounded product, your endocrinologist will often recheck after every refill until stability is documented [C1].
6. Revisit the decision yearly. New FDA-approved liquid and softgel formulations have closed many of the historical reasons to compound [C6]. What required a compounded capsule in 2018 may now be solved by a manufactured product.

Frequently asked questions

Is compounded thyroid the same as Armour or natural desiccated thyroid? No. Armour, NP Thyroid, and similar NDT products are FDA-approved manufactured tablets [C5]. Compounded thyroid is mixed by a pharmacy for an individual patient and is not FDA-approved.

Will compounded T4/T3 cure my Hashimoto's? No. Hashimoto's is a chronic autoimmune disease and no thyroid hormone formulation reverses the underlying process [C2][C3]. Compounded products treat the hormone deficiency only.

Are compounded capsules safer because they have "no fillers"? Not necessarily. Compounded capsules still contain a filler — usually microcrystalline cellulose or a similar inert powder — but they avoid the specific excipient a patient reacted to. They also trade away FDA potency oversight, which is a meaningful safety consideration on its own [C1].

My TSH bounces around on a compounded product. Is that normal? TSH variability is a recognized issue with compounded thyroid and can come from batch-to-batch potency differences [C1][C4]. Your endocrinologist will check whether the same pharmacy and the same lot are being used, and may recommend switching back to an FDA-approved tablet or liquid.

How do I find a reputable compounding pharmacy? Ask for a 503A (patient-specific) or 503B (outsourcing) pharmacy that complies with USP standards and shares potency-testing data. Your endocrinologist will usually have a short list of pharmacies they trust for thyroid compounding in your area.

Bottom line

Compounded thyroid medications have a narrow but real role: confirmed allergy to inactive ingredients in commercial tablets, an individualized T4/T3 ratio that no manufactured product can deliver, or micro-doses for pediatric use [C1][C7]. They are not FDA-approved, potency varies more than with manufactured tablets, and TSH should be monitored more often [C1][C4]. Before agreeing to a compounded prescription, try a dye-free generic, a liquid, or a softgel — these solve most filler and dosing problems without giving up FDA oversight [C6]. When compounding is the right answer, use a reputable 503A or 503B pharmacy, stay with one source, and revisit the decision every year [C1][C7][C8].